Infamous pharma executive took a huge hit
Martin Shkreli may need to post fresh collateral for bail after shares of KaloBios Pharmaceuticals fell 90% since December.
Infamous pharma executive took a huge hit
Martin Shkreli may need to post fresh collateral for bail after shares of KaloBios Pharmaceuticals fell 90% since December.